As on Thursday, Unicycive Therapeutics Inc (NASDAQ: UNCY) started slowly as it slid -5.15% to $0.30, before settling in for the price of $0.32 at the close. Taking a more long-term approach, UNCY posted a 52-week range of $0.20-$1.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -5.80% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -77.09%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 42.19%. This publicly-traded company’s shares outstanding now amounts to $85.68 million, simultaneously with a float of $75.86 million. The organization now has a market capitalization sitting at $25.70 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4923, while the 200-day Moving Average is $0.8741.
Unicycive Therapeutics Inc (UNCY) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Unicycive Therapeutics Inc’s current insider ownership accounts for 11.47%, in contrast to 29.25% institutional ownership.
Unicycive Therapeutics Inc (UNCY) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
Unicycive Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 42.19% and is forecasted to reach -0.11 in the upcoming year.
Unicycive Therapeutics Inc (NASDAQ: UNCY) Trading Performance Indicators
Let’s observe the current performance indicators for Unicycive Therapeutics Inc (UNCY). It’s Quick Ratio in the last reported quarter now stands at 3.37. The Stock has managed to achieve an average true range (ATR) of 0.06.
In the same vein, UNCY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.89, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.11 at the market close of one year from today.
Technical Analysis of Unicycive Therapeutics Inc (UNCY)
Through scrutinizing the latest numbers posted by the [Unicycive Therapeutics Inc, UNCY], it can be observed that its last 5-days Average volume of 8.39 million was better the volume of 0.99 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 35.62% While, its Average True Range was 0.0564.
Raw Stochastic average of Unicycive Therapeutics Inc (UNCY) in the period of the previous 100 days is set at 7.01%, which indicates a major fall in contrast to 35.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 212.48% that was higher than 126.92% volatility it exhibited in the past 100-days period.
